330
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

One new sesquiterpene pyridine alkaloid from the stems and leaves of Euonymus fortunei

, , , , , , , , & show all
Pages 399-406 | Received 05 Dec 2019, Accepted 09 Apr 2020, Published online: 22 Apr 2020
 

Abstract

A new sesquiterpene pyridine alkaloid (1), along with four known compounds (2-5), were isolated from the stems and leaves of Euonymus fortunei. The new structure was determined by extensive spectroscopic analyses (IR, UV, NMR, HRESIMS and ECD). In addition, compound 3 showed a stronger anti-respiratory syncytial virus (RSV) activity with an IC50 value of 1.20 ± 0.10 µM than the positive control ribavirin with an IC50 value of 5.62 ± 0.49 µM.

Graphical Abstract

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was financially supported by grants from the National Key R&D Program of China (No. 2017YFC1703800), Natural Science Foundations of China (Nos. 81803376, 81673319, and 81673670), Science and Technology Planning Project of Guangzhou City (Nos. 201904010447, 201707010399), Natural Science Foundation of Guangdong Province (No. 2018B030311020, 2017A030313732), China Postdoctoral Science Foundation (No. 2019T120795), and Science and Technology Planning Project of Shenzhen City (JCYJ20170818162249554).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.